Breath testing for coronavirus
The government may have reached its 100,000 test goal but response times for test results remain in the days category. It has been reported that a faster test will be needed to reliably enforce isolation quickly and effectively.
ANCON Medical’s Nanoparticle Biomarker Tagging (NBT) device works with AI and machine learning to identify the breath biomarker profile of a COVID-19 positive patient – allowing the device to diagnose the presence of the disease in as little as 10 minutes, without the need to send samples to labs, as is currently the case. It can also provide rapid response screening and diagnosis technique for future outbreaks.
Read previous article
Aerosol particles of COVID-19 travel over 30m distance
Read next article
Innovation To Tackle Regional Covid Hotspots